In the physiological state, mitochondrial fission and fusion are in dynamic equilibrium, with each process holding the other in check
In its lawsuit, the OFA said that the FDAs decision to end the shortage was a reckless and arbitrary move and could deprive patients of a vital treatment for type 2 diabetes and obesity. In an interview with BioSpace last month, David Rosen, partner at Foley & Lardner, said that the lawsuit is a precedent in this area. Prior to the OFA suit, no one has ever challenged the FDAs decision to remove a therapy from the drug shortage list. The OFA case is still ongoing, with the next court update due on Thursday
BPC-157 is a synthetic 15-amino-acid peptide fragment originally isolated from human gastric juice, where it occurs as part of a larger body-protective protein
Next-generation dermal renewal for firmer, smoother, more sculpted-looking skin
Residual solvents Likewise, Use headspace GC-FID or GC-MS with a process-specific panel and science-based limits
10.1038/nature07450 Nature
